Erschienen in:
01.02.2019 | Invasive Electrophysiology and Pacing (EK Heist, Section Editor)
Management of Atrial Fibrillation in Patients with Heart Failure: Time to Implement Ablation Control
verfasst von:
Alex Baher, Nassir F. Marrouche
Erschienen in:
Current Cardiology Reports
|
Ausgabe 2/2019
Einloggen, um Zugang zu erhalten
Abstract
Purpose of the Review
Atrial fibrillation (AF) in patients with heart failure and reduced systolic ejection fraction (HFrEF) is common and associated with increased morbidity and mortality, and managing AF in this population has been particularly challenging with sparse data regarding the optimal treatment strategy.
Recent Findings
Recent data suggests that rhythm control with catheter ablation can be of particular benefit to patients with coexisting AF and HFrEF. Recent randomized control trials actually suggest that catheter ablation could potentially improve mortality in this particular patient population. This is in stark contrast to the current practice recommendations that reserve catheter ablation for symptomatic AF in the general population.
Summary
In this paper, we will review the most current randomized controlled studies using catheter ablation in HFrEF patients with the hope to increase awareness of the potential mortality benefits the need for prioritization of catheter ablation in HFrEF patients in the next AF management guidelines.